Bluejay Diagnostics (BJDX) Other financing activities (2021 - 2026)

Bluejay Diagnostics has disclosed Other financing activities across 6 years of filings, most recently posting $1051.0 for Q1 2026.

• Other financing activities for Q1 2026 came in at $1051.0, up 6.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 10.41% YoY), and the FY2025 annual result was $1.3 million, down 32.1% from the prior year.
• Other financing activities came in at $1051.0 for Q1 2026 at Bluejay Diagnostics, down from $1.2 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $1.8 million in Q4 2024 to a low of -$709187.0 in Q2 2024.
• The 5-year median for Other financing activities is $27702.0 (2023), against an average of $249578.0.
• Across the five-year window, Other financing activities surged 59053.99% in 2024 and tumbled 48851.43% in 2025, its largest moves.
• Bluejay Diagnostics' Other financing activities stood at $106114.0 in 2022, then plunged by 127.24% to -$28904.0 in 2023, then jumped by 6471.64% to $1.8 million in 2024, then tumbled by 32.16% to $1.2 million in 2025, then sank by 99.92% to $1051.0 in 2026.
• The last three Other financing activities figures came in at $1051.0 (Q1 2026), $1.2 million (Q4 2025), and -$461676.0 (Q3 2025), per Business Quant data.